Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
VAS | Ann: Exit Statement | 29/07/25 | 0 | 151 | |||
|
|||||||
VAS | Ann: FATCA and CRS Tax Residency Certification Reminder | 24/07/25 | 0 | 170 | |||
|
|||||||
VAS | Ann: Outstanding ETF Securities and Fund Flows Announcement | 07/07/25 | 0 | 211 | |||
|
|||||||
VAS | Ann: DRP Issue Price Announcement | 02/07/25 | 0 | 196 | |||
|
|||||||
VAS | Ann: Distribution Tax Estimates | 02/07/25 | 0 | 186 | |||
|
|||||||
VAS | Ann: Final Distribution Announcement | 02/07/25 | 0 | 255 | |||
|
|||||||
VAS | Ann: Updated Estimated Distribution Announcement | 01/07/25 | 0 | 221 | |||
|
|||||||
VAS | Ann: Updated Product Disclosure Statement | 30/06/25 | 0 | 142 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |